• Make a CBD Sweetener: Another popular method of using CBD isolate involves making it into sort of a sweetener, though as we mentioned above CBD should be tasteless. To make your own CBD “sweetener”, heat up honey or agave in a double boiler (or something similar), and then mix in your CBD isolate until thoroughly dissolved. Use this infused sweetener on top of toast, in your tea or coffee, or even by the spoonful.
In February 2015, the FDA sent warning letters to six companies selling CBD as a dietary supplement. The letters informed business owners that they could not sell CBD by promoting it as “intended for use in the cure, mitigation, treatment, or prevention of disease,” since it is not cleared for these purposes by the FDA. In 2016, the FDA sent letters to eight more companies.
Thapa, D., Toguri, J. T., Szczesniak, A. M., & Kelly, A. E. M. (2017, April 1). The non-psychoactive phytocannabinoid, cannabidiol (CBD), and the synthetic derivatives, HU308 and CBD-DMH, reduces hyperalgesia and inflammation in a mouse model of corneal injury [Abstract]. FASEB Journal. Retrieved from https://www.fasebj.org/doi/abs/10.1096/fasebj.31.1_supplement.811.7
CBD oil extracted from hemp — no matter how it’s consumed — works with the body’s ECS system to replenish cannabinoids and regulate homeostasis. The substance is also anti-anxiolytic, meaning it reduces feelings of anxiety — a common source of sleep problems in adults. For these reasons, hemp-based CBD oil can be highly beneficial for people with insomnia whether they struggle with sleep onset (falling asleep) or sleep maintenance (staying asleep). In addition to insomnia, CBD oil may lead to improvements for the following sleep disorders:
Cannabidiol has been found to act as an antagonist of GPR55, a G protein-coupled receptor and putative cannabinoid receptor that is expressed in the caudate nucleus and putamen in the brain. It has also been found to act as an inverse agonist of GPR3, GPR6, and GPR12. Although currently classified as orphan receptors, these receptors are most closely related phylogenetically to the cannabinoid receptors. In addition to orphan receptors, CBD has been shown to act as a serotonin 5-HT1A receptor partial agonist, and this action may be involved in its antidepressant, anxiolytic, and neuroprotective effects. It is an allosteric modulator of the μ- and δ-opioid receptors as well. The pharmacological effects of CBD have additionally been attributed to PPARγ agonism and intracellular calcium release.
The extract known as CBD oil sold in the U.S. falls into one of two categories. Crystalline isolate exclusively contains CBD, as other cannabinoids have been removed; full spectrum oil, on the other hand, retains THC and other cannabinoids, and is only sold in states where marijuana use has been legalized. CBD oil can be consumed several different ways, including ingested capsules and food products, vaporizing, tinctures, and topical creams. The soporific effects of CBD oil are linked to its concentration; low-concentration oils will produce minimal effects, while high-concentration oils will produce strong effects.